Cognitive dysfunction in patients with multiple sclerosis treated with first-line disease-modifying therapy: a multi-center, controlled study using the BICAMS battery
Crossref DOI link: https://doi.org/10.1007/s10072-016-2775-7
Published Online: 2016-11-24
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cinar, Bilge Piri
Kösehasanoğulları, Görkem
Yigit, Pinar
Ozakbas, Serkan
License valid from 2016-11-24